Robin Hood Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
S2N Health provides commercial intelligence, analytics, and go-to-market strategy services for medtech, diagnostics, digital health, and drug delivery companies, from startups to global enterprises.
AI & Machine LearningHealthtechMedical DevicesSales TechBoston, US
Amy Siegel(CEO & Co-Founder)inTim Kofol(CTO & Co-Founder)inLeah Shea(Chief Product Officer)in
BoardRoome Hugh(Director)Andrew Schwab(Director)inMartha Shadan(Director)in
PartnerPitou Devgon· solo GP
Co-investorsExcelerate Health VenturesRittenhouse VenturesBoston Millennia Partners
Vytala develops a plant-based medical food using its Lym-X-Sorb lipid technology to improve absorption of dietary fat, choline, and essential fatty acids in patients with fat malabsorption from conditions such as cystic fibrosis and pancreatic insufficiency.
BiotechDigital HealthHealthtech
Jim O'Connell(Founder)in
PartnerPitou Devgon· solo GP
Co-investorsDelaware Crossing Investor GroupThe MBA FundUlu Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.